Google
ORMP 株価分析 — Oramed Pharmaceuticals Inc (Healthcare >> Biotechnology)
ORMP に関するよくある質問
ORMPのPER（株価収益率）は？
Oramed Pharmaceuticals Inc（ORMP）は現在PER 1.51倍で取引されています。
ORMPのROE（自己資本利益率）は？
Oramed Pharmaceuticals IncのROEは46.17%です。
ORMPの配当利回りは？
Oramed Pharmaceuticals Incの配当利回りは0.00%です。
ORMPの品質スコア（Quality Score）は？
当社のAIはORMPの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ORMPは今が買い時ですか？
当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ORMPはどのセクターに属しますか？
Oramed Pharmaceuticals IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
ORMP AI Analysis Summary
Our AI summary for ORMP: Oramed Pharmaceuticals Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 1.51, ROE of 46.17%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 4.07
Price
-0.05
(-1.21%)
Day Change
|
|
|---|
ORMP, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are ok , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
64% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
34
GREAT
|
| Magic Formula Rank by ROE |
34
GREAT
|
| Magic Formula Rank by ROIC |
54
GOOD
|
| Price | 4.07 |
| PBV / Sector |
0.70 / 5.20
GREAT
|
| Earning Per Share | 2.69 |
| PE / Sector |
1.51 / 19.97
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 1.22
|
| Average 1M Daily Value |
0.74 M
GREAT
|
| Average 1W Daily Value |
0.55 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:17 |
| Symbol | ORMP |
| Name | ORAMED PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 40.93 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 166.57 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
Phone: 844 967 2633
Website: https://oramed.com
Sector: Healthcare >> Biotechnology
Description: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
